Condition
Intracerebral Haemorrhage (ICH)
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 3 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07237048Phase 2Recruiting
Minocycline in Stroke Study at Maimonides
NCT07053917Phase 1Recruiting
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
NCT02699645Phase 3CompletedPrimary
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial
NCT06816641Not ApplicableRecruitingPrimary
Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
NCT02513316Completed
Clinical Relevance of Microbleeds In Stroke
Showing all 5 trials